Congratulations to Dr. Sylvain Doré!

Dr. Doré has been awarded a grant in the amount of $225,000 from the Ed and Ethel Moore Alzheimer’s Disease Research Program to fund his grant titled “Therapeutic potential of PGE2 EP1 receptor selective antagonist”.